Newsbenzinga
Dyne Therapeutics' Biologics License Application For Zeleciment Rostudirsen Got FDA Acceptance For Review To Treat Duchenne Muscular Dystrophy
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…